文献速递胸部肿瘤放疗放疗物理与技术

I期肺癌碳离子放疗剂量分布验证

Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2016-09-14

肿瘤位移和水等效路径长度变化是不可接受病例的显著预测因素,6 mm计划靶体积边界可确保GTV %D95大于90%(除1个极端不可接受野外)。

要点

  • 肿瘤位移(P<.001)和水等效路径长度变化(P=.002)是不可接受病例的显著预测因素。
  • 6 mm计划靶体积边界可确保GTV %D95大于90%,仅1个极端不可接受野例外。

核心结论

  • I期NSCLC碳离子放疗中少数照射野剂量分布不可接受,需重新摆位并确认。
  • 肿瘤位移和水等效路径长度变化是影响剂量分布稳健性的因素,计划时应考虑这些不确定性。

研究设计与样本

  • 在与实际治疗相同设置下(呼吸门控和骨性结构匹配)重建模拟剂量分布,计算剂量体积直方图参数如%D95。

主要发现

  • 5例患者共8个野(占总分析野数10%)因GTV %D95低于90%被判定为不可接受。
  • 大多数患者剂量体积直方图参数无显著变化。
  • 8个不可接受野中7个的主要原因是肿瘤位移。
  • 受试者工作特征曲线分析显示肿瘤位移和水等效路径长度变化是显著预测因素(分别为P<.001和P=.002)。

关键数值与推荐

  • GTV %D95低于90%的照射野被判定为不可接受。
  • 6 mm计划靶体积边界可确保GTV %D95大于90%,除1个极端不可接受野外。

临床怎么用

  • 碳离子放疗计划时应考虑肿瘤位移和水等效路径长度变化对剂量分布的影响。
  • 对模拟验证中不可接受的照射野需重新摆位并再次确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate robustness of dose distribution of carbon-ion radiation therapy (C-ion RT) in non-small cell lung cancer (NSCLC) and to identify factors affecting the dose distribution by simulated dose distribution. METHODS AND MATERIALS: Eighty irradiation fields for delivery of C-ion RT were analyzed in 20 patients with stage I NSCLC. Computed tomography images were obtained twice before treatment initiation. Simulated dose distribution was reconstructed on computed tomography for confirmation under the same settings as actual treatment with respiratory gating and bony structure matching. Dose-volume histogram parameters, such as %D95 (percentage of D95 relative to the prescribed dose), were calculated. Patients with any field for which the %D95 of gross tumor volume (GTV) was below 90% were classified as unacceptable for treatment, and the optimal target margin for such cases was examined. RESULTS: Five patients with a total of 8 fields (10% of total number of fields analyzed) were classified as unacceptable according to %D95 of GTV, although most patients showed no remarkable change in the dose-volume histogram parameters. Receiver operating characteristic curve analysis showed that tumor displacement and change in water-equivalent pathlength were significant predictive factors of unacceptable cases (P<.001 and P=.002, respectively). The main cause of degradation of the dose distribution was tumor displacement in 7 of the 8 unacceptable fields. A 6-mm planning target volume margin ensured a GTV %D95 of >90%, except in 1 extremely unacceptable field. CONCLUSIONS: According to this simulation analysis of C-ion RT for stage I NSCLC, a few fields were reported as unacceptable and required resetting of body position and reconfirmation. In addition, tumor displacement and change in water-equivalent pathlength (bone shift and/or chest wall thickness) were identified as factors influencing the robustness of dose distribution. Such uncertainties should be regarded in planning.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Irie D, Saitoh JI, Shirai K, et al. Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung Cancer. Int J Radiat Oncol Biol Phys. 2016. PMID: 27869084. doi:10.1016/j.ijrobp.2016.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。